ACTU
Actuate Therapeutics, Inc.
0.62$
-15.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -9.9% | -35.9% | +724.0% | -34.7% | -51.9% | +55.5% | +154.2% | -20.8% | -36.5% | -41.7% | |
| – | – | -27.0% | -74.9% | +2,494.7% | -35.4% | -53.9% | +57.4% | +160.8% | -21.8% | -37.6% | -44.3% | |
| – | – | -30.1% | -83.0% | +3,745.1% | -36.1% | -55.0% | +66.9% | +160.7% | -22.2% | -38.2% | -45.6% | |
| – | – | -30.1% | -83.0% | +3,745.1% | -36.1% | -55.0% | +66.9% | +160.7% | -22.2% | -38.2% | -45.6% | |
| – | – | +7.7% | +5.0% | -92.3% | +3.5% | +3.9% | +0.5% | -29.6% | -9.8% | -16.1% | -17.9% | |
| – | – | +112.9% | +36.2% | -57.7% | +3.6% | +4.0% | +0.5% | -30.7% | -10.4% | -17.3% | -19.4% | |
| – | – | – | +38.0% | – | – | – | – | – | – | – | – | |
| – | – | +15.6% | +49.0% | -60.5% | -17.5% | +37.6% | +19.9% | -60.7% | +22.4% | -21.2% | -10.4% | |
| – | – | – | – | – | -98.1% | -4,983.3% | – | – | -27.5% | -52.2% | -73.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.5% | +1.5% | +26.1% | -0.1% | +0.0% | -0.1% | +0.8% | +8.9% | +8.6% | +1.3% | +1.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.